Serbian Biomarker Symposium

SERBIS 2020

7th Serbian Biomarker Symposium

Biomarkers of gastrointestinal diseases

April

 

 

Day One.

 

WEDNESDAY, April 08th, 2020 Postponed

 

Room Atlantic/Pacific

 

07:30-08:30

Registration

 

 

 

Session 1

Chairs: Aleksandra SOKIC MILUTINOVIC, Dino TARABAR

 

08:30-08:50

Inflammatory bowel disease (IBD) in 2020

Prof. Aleksandra SOKIC MILUTINOVIC, Serbia

 

08:50-09:10

Pediatric onset of IBD - what we need to know?

Dr Ivan MILOVANOVIC, Serbia

 

09:10-09:30

Therapeutic strategy in IBD today

Prof. Dino TARABAR, Serbia

 

09:30-09:50

Achieving mucosal healing in IBD:

which drug concentrations need to be targeted?

Debby THOMAS, Belgium

 

09:50-10:05

Haemostasis and IBD

Prof. Gorana MITIC, Serbia

 

10:05-10:20

Evolving role of IBD surgery

Prof. Goran BARISIC, Serbia

 

10:20-10:35

Q&A (Discussion)

 

 

 

Session 2

Chairs: Joris DELANGHE, Peter KONTUREK

 

10:35-10:55

Diagnosis and follow up of IBD calprotectin

Dr Arne ROSETH, Norway

 

10:55-11:15

Fecal calprotectin as a useful marker in discriminating between IBD and functional gatrointestinal disorders

Prof. Peter KONTUREK, Germany

 

11:15-11:35

Trypsin activity is a confounder in the interpretation of calprotectin tests

Prof. Joris DELANGHE, Belgium

 

11:35-11:45

Fecal calprotectin in assesment of histologic disease activity in patients with ulcerative colitis

Dr Tamara KNEZEVIC IVANOVSKI, Serbia

 

11:45-11:55

Fecal analysis  in IBD, is fecal lactoferin the one?

Dr Ljubisa TONCEV, Serbia

 

11:55-12:10

Q&A (Discussion)

 

12:10-12:45

Plenary lecture

Next-generation sequencing approach for the diagnosis of human diseases

Prof. Maurizio FERRARI, Italy

 

12:45-13:15

Workshop

 

13:15-14:00

Lunch break

 

14:00-14:30

Workshop

 

 

 

Session 3

Chairs: Kari SYRJÄNEN, Srdjan DJURANOVIC

 

14:30-14:50

Volatile organic compounds as biomarkers of gastrointestinal diseases

Prof. Sergio BERNARDINI, Italy

 

14:50-15:10

Helicobacter pylori infection 2020 – screen and treat all?

Prof. Srdjan DJURANOVIC, Serbia

 

15:10-15:30

The GastroPanel® test: characteristics of the biomarker panel and its performance in diagnosis and screening

Prof. Kari SYRJÄNEN, Finland

 

15:30-15:50

Clostridium difficile infection as a growing challenge: advances in the diagnosis and treatment

Prof. Milos KORAC, Serbia

 

15:50-16:05

Q&A (Discussion)

 

 

 

Session 4

Chairs: Mirjana RAJILIC-STOJANOVIC, Maurizzio SIMACO

 

16:05-16:25

Irritable bowel syndrome: intestinal microbiota and diet

Asst. Prof. Mirjana RAJILIC-STOJANOVIC, Serbia

 

16:25-16:45

Microbiome and response to drugs

Prof. Maurizzio SIMACO, Italy

 

16:45-17:05

Analysis of transcriptionally active bacteria throughout the gastrointestinal tract of healthy individuals

Dr Riccardo VASAPOLLI, Germany

 

17:05-17:20

Q&A (Discussion)

 

 

 

Session 5

Chairs: Ivan JOVANOVIC, Ivan STANKOVIC

 

17:20-17:40

Gluten-related disorders: where are we and where are we going?

Prof. Ivan JOVANOVIC, Serbia

 

17:40-18:00

Non invasive markers of celiac disease

Asst. dr Sanja DRAGASEVIC, Serbia

 

18:45-18:20

Food for special dietary use for persons intolerant to gluten – international standards and legislation

Prof. Ivan STANKOVIC, Serbia

 

18:20-18:40

HLA DQ2/8 genotyping in exclusion of celiac diseases

Prof. Janja MARC, Slovenia

 

18:40-19:00

Biomarkers and mechanisms in food allergy

Dr Ivan RANKOVIC, Serbia

 

19:00-19:15

Q&A (Discussion)

 

 

Next day >

 

 

 

 

Under the auspices of